Literature DB >> 15695305

Guideline for anti-TNF-alpha therapy in psoriatic arthritis.

S Kyle1, D Chandler, C E M Griffiths, P Helliwell, J Lewis, I McInnes, S Oliver, D Symmons, N McHugh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15695305     DOI： 10.1093/rheumatology/keh514

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  23 in total

Review 1.  Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotype?

Authors:  William Tillett; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

Review 2.  Golimumab for the treatment of psoriatic arthritis: a NICE single technology appraisal.

Authors:  Huiqin Yang; Dawn Craig; David Epstein; Laura Bojke; Kate Light; Ian N Bruce; Mark Sculpher; Nerys Woolacott
Journal:  Pharmacoeconomics       Date:  2012-04       Impact factor: 4.981

Review 3.  Treatment advances in psoriatic arthritis.

Authors:  Eric M Ruderman
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

Review 4.  TNFalpha blockade in human diseases: an overview of efficacy and safety.

Authors:  Jan Lin; David Ziring; Sheetal Desai; Sungjin Kim; Maida Wong; Yael Korin; Jonathan Braun; Elaine Reed; David Gjertson; Ram Raj Singh
Journal:  Clin Immunol       Date:  2007-10-04       Impact factor: 3.969

5.  Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate.

Authors:  J Gratacós; E Casado; J Real; J C Torre-Alonso
Journal:  Ann Rheum Dis       Date:  2006-12-19       Impact factor: 19.103

6.  Cost effectiveness of golimumab for the treatment of active psoriatic arthritis.

Authors:  Ewen Cummins; Christian Asseburg; Manishi Prasad; Jacqueline Buchanan; Yogesh Suresh Punekar
Journal:  Eur J Health Econ       Date:  2011-07-01

Review 7.  Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents.

Authors:  Wolfgang Weger
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

8.  Prevalence and treatment patterns of psoriatic arthritis in the UK.

Authors:  Alexis Ogdie; Sinéad Langan; Thorvardur Love; Kevin Haynes; Daniel Shin; Nicole Seminara; Nehal N Mehta; Andrea Troxel; Hyon Choi; Joel M Gelfand
Journal:  Rheumatology (Oxford)       Date:  2012-12-07       Impact factor: 7.580

Review 9.  Regulatory mechanisms of helper T cell differentiation: new lessons learned from interleukin 17 family cytokines.

Authors:  Bhanu P Pappu; Pornpimon Angkasekwinai; Chen Dong
Journal:  Pharmacol Ther       Date:  2008-01-19       Impact factor: 12.310

10.  Update on the treatment of peripheral arthritis in psoriatic arthritis.

Authors:  Enrique R Soriano; Javier Rosa
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.